L. Matrisian
Oncology · 2000–2021
A researcher in the Science corpus: 12 papers; trusts 4 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 49 citations into it; #117 of 1,698 by trust here, #203 by citations
- Cancer Research — 37 citations into it; #188 of 1,780 by trust here, #209 by citations
- Molecular Biology — 28 citations into it; #3,849 of 17,773 by trust here, #2,679 by citations
- Hematology — 13 citations into it; #85 of 225 by trust here, #108 by citations
Whom L. Matrisian trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Matrisian overall
- I. Stamenkovic
- B. Turk
- Christopher M. Overall
- C. Malemud
- C. Brinckerhoff
- W. Parks
- C. López‐Otín
- Zena Werb
Papers from L. Matrisian's perspective
Ordered by how strongly the researchers L. Matrisian trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
- Cysteine cathepsins: multifunctional enzymes in cancer (Nature Reviews. Cancer)
- Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. (Cell)
- Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? (Nature Reviews. Cancer)
- Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment (Nature Medicine)
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (Nature Medicine)
- MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. (Cancer Cell)
- Protease degradomics: A new challenge for proteomics (Nature reviews. Molecular cell biology)
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization (Nature)
Their papers
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (2002) — 2,778 citations
- Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. (2004) — 1,178 citations
- Matrix metalloproteinases: biologic activity and clinical implications. (2000) — 1,568 citations
- Matrix metalloproteinases: they're not just for matrix anymore! (2001) — 1,336 citations
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research (2009) — 1,349 citations
- Estimated Projection of US Cancer Incidence and Death to 2040 (2021) — 1,095 citations
- Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. (2014) — 6,276 citations
- Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. (2008) — 952 citations
- Emerging roles of proteases in tumour suppression (2007) — 826 citations
- Matrix metalloproteinases: a tail of a frog that became a prince (2002) — 1,149 citations
- Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. (2001) — 754 citations
- Matrix metalloproteinases: multifunctional contributors to tumor progression. (2000) — 666 citations